Medtronic (MDT) FCF Payout Ratio Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -51.96% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9,472.45% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 2.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -7.45% |
| Oct 24, 2025 | 22.98% |
| Jul 25, 2025 | -19.14% |
| Apr 25, 2025 | 11.64% |
| Jan 24, 2025 | -0.69% |
| Oct 25, 2024 | -64.72% |
| Jul 26, 2024 | 9.37% |
| Apr 26, 2024 | -10.66% |
| Jan 26, 2024 | -40.80% |
| Oct 27, 2023 | 204.14% |
| Jul 28, 2023 | 28.20% |
| Apr 28, 2023 | -13.99% |
| Jan 27, 2023 | 63.10% |
| Oct 28, 2022 | 166.91% |
| Jul 29, 2022 | 48.49% |
| Apr 29, 2022 | -11.47% |
| Jan 28, 2022 | 13.88% |
| Oct 29, 2021 | 14.53% |
| Jul 30, 2021 | 106.66% |
| Apr 30, 2021 | -12.16% |
| Jan 29, 2021 | 14.58% |
| Oct 30, 2020 | 8.16% |
| Jul 31, 2020 | -2,419.95% |
| Apr 24, 2020 | 69.69% |
| Jan 24, 2020 | -10.65% |
| Oct 25, 2019 | -35.19% |
| Jul 26, 2019 | 24.81% |
| Apr 26, 2019 | -54.21% |
| Jan 25, 2019 | 7.52% |
| Oct 26, 2018 | -25.16% |
| Jul 27, 2018 | -64.76% |
| Apr 27, 2018 | 103.20% |
| Jan 26, 2018 | 6.14% |
| Oct 27, 2017 | 91.06% |
| Jul 28, 2017 | 177.33% |
| Apr 28, 2017 | -24.57% |
| Jan 27, 2017 | -2.46% |
| Oct 28, 2016 | -3.05% |
| Jul 29, 2016 | -45.97% |
| Apr 29, 2016 | 107.88% |
| Jan 29, 2016 | 90.39% |
| Oct 30, 2015 | 38.43% |
| Jul 31, 2015 | -39.91% |